FDA Publishes Guidance For Biopharma Container Labels Carton Labeling Design

The scope of this new FDA guidance includes prescription drug products marketed under an approved NDA or ANDA, prescription drugs marketed without an...

Related Keywords

,Mark Durivage ,Institute Of Medicine ,Institute For Safe Medication Practices ,Drug Administration ,Chapters ,Quality Systems Compliance ,National Patient Safety Agency ,Drug Evaluation ,Biologics Evaluation ,Safety Considerations ,Container Labels ,Carton Labeling Design ,Minimize Medication Errors Guidance ,Preventing Medication Errors ,Labeling Considerations ,General Biological Products Standards ,United States Pharmacopeia ,Product Design ,Minimize Medication Errors ,Information Design ,Patient Safety ,Graphic Design ,Medication Packaging ,Injectable Medicines ,Safe Medication Practices ,Error Prone Abbreviations ,Dose Designations ,Potassium Chloride ,Injection Concentrate ,Bulk Package ,Single Patient Use Only ,Dockets Management Staff ,